levofloxacin + ceftriaxone

Levofloxacin + ceftriaxone is a combination of two broad-spectrum antibiotics used primarily for the treatment of severe bacterial infections, including pneumonia and meningitis, especially those caused by drug-resistant organisms. Levofloxacin is a fluoroquinolone antibiotic that exerts its bactericidal effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and cell division[6]. Ceftriaxone is a third-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death[8]. The combination has demonstrated synergistic effects in both in vitro and animal models against multidrug-resistant Streptococcus pneumoniae, resulting in enhanced bacterial killing, reduced inflammation, downregulation of virulence factors (such as pneumolysin and autolysin), and decreased development of antibiotic resistance compared to monotherapy[1][2][3][5].

Brand names

Rocephin

Other names

levofloxacin + ceftriaxone